Haplotype Analysis of the First A4V-SOD1 Spanish Family: Two Separate Founders or a Single Common Founder?

Altres autors/es

Institut Català de la Salut

[Garcia C, Vidal-Taboada JM] Unitat Esclerosi Lateral Amiotròfica (ELA), Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Barcelona, Spain. [Syriani E, Morales M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Barcelona, Spain. [Salvado M, Gamez J] Unitat Esclerosi Lateral Amiotròfica (ELA), Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2021-04-09T11:01:21Z

2021-04-09T11:01:21Z

2019-11-08



Resum

A4V; SOD1; Esclerosi lateral amiotròfica


A4V; SOD1; Esclerosis lateral amiotrófica


A4V; SOD1; Amyotrophic lateral sclerosis


Despite the genetic heterogeneity reported in familial amyotrophic lateral sclerosis (ALS) (fALS), Cu/Zn superoxide-dismutase (SOD1) gene mutations are the second most common cause of the disease, accounting for around 20% of all families (ALS1) and isolated sporadic cases (sALS). At least 186 different mutations in the SOD1 gene have been reported to date. The possibility of a single founder and separate founders have been investigated for D90A (p.D91A) and A4V (p.A5V), the most common mutations worldwide. High-throughput single nucleotide polymorphism genotyping studies have suggested two founders for A4V (one for the Amerindian population and another for the European population) although the possibility that the two populations are descended from a single ancient founder cannot be ruled out. We used 15 genetic variants spanning the human chromosome 21 from the SOD1 gene to the SCAF4 gene, comparing them with the population reference panels, to demonstrate that the first A4V Spanish pedigree shared the genetic background reported in the European population.


This study has been supported by Instituto de Salud Carlos III (grant numbers PIS-FEDER PI16/01673 and PI19/00593). JG and JV-T are the recipients of grant 2017SGR00939 from Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Frontiers Media

Documents relacionats

Frontiers in Genetics;10

https://www.frontiersin.org/article/10.3389/fgene.2019.01109/full

info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01673

info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00593

info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR00939

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)